Group 1 - Haleon reported a total revenue of £11.03 billion for the full-year 2025, with the Oral Health sector achieving approximately 8% organic growth [2] - The company maintained or gained market share in 60% of its business segments, driven by productivity initiatives such as a 26% reduction in SKU complexity and optimized logistics [2] - Despite challenges in North America due to low consumer confidence and a weak cold and flu season, Haleon experienced strong growth in the EMEA, Latin America, and Asia-Pacific regions [1][5] Group 2 - For 2026, Haleon anticipates organic revenue growth to accelerate to between 3% and 5%, supported by a new operating model aimed at increasing agility [3] - The company has created a Chief Growth Officer role and restructured into six specific operating units to better capture regional opportunities [3] - Management plans to achieve high single-digit adjusted operating profit growth and has allocated £500 million for share buybacks in the upcoming year [3]